The rational design of fungal lanosterol C14 demethylase inhibitors
Marriott, M.S.
Molecular aspects of chemotherapy Proceedings of the Second International Symposium, Gdansk, Poland, July 5-8, 1988: 193-204
1990
Accession: 002257134
The rational design of medically important inhibitors of fungal lanosterol C14 demethylase such as azoles is discussed in terms of structure-activity relationships relevant to intrinsic potency and in vitro and in vivo activity.
PDF emailed within 1 workday: $29.90
Related References
Monk, B.C.; Sagatova, A.A.; Hosseini, P.; Ruma, Y.N.; Wilson, R.K.; Keniya, M.V. 2020: Fungal Lanosterol 14α-demethylase: a target for next-generation antifungal design Biochimica et Biophysica Acta. Proteins and Proteomics 1868(3): 140206Shukla, P.; Deswal, D.; Azad, C.S.; Narula, A.K. 2019: Novel nucleosides as potential inhibitors of fungal lanosterol 14α-demethylase: an in vitro and in silico study Future Medicinal Chemistry 11(20): 2663-2686
Han, G.; Liu, N.; Li, C.; Tu, J.; Li, Z.; Sheng, C. 2020: Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis Journal of Medicinal Chemistry 63(10): 5341-5359
González-Chávez, R.; Martínez, R.; Torre-Bouscoulet, M.ía.E.; Gallo, M.; González-Chávez, M.M.ín. 2014: De novo design of non-coordinating indolones as potential inhibitors for lanosterol 14-α-demethylase (CYP51) Chemical and Pharmaceutical Bulletin 62(1): 16-24
Stana, A.; Vodnar, D.C.; Tamaian, R.; Pîrnău, A.; Vlase, L.; Ionuț, I.; Oniga, O.; Tiperciuc, B.în.şa. 2017: Design, Synthesis and Antifungal Activity Evaluation of new Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors International Journal of Molecular Sciences 18(1)
Magolda, R.L.; Chen, H.; Favata, M.F.; Fischer, R.T.; Gaylor, J.L.; Johnson, P.R.; K.S.S.; Molaison, C.K.; Stam, S.H.; Trzaskos, J.M. 1988: Design and synthesis of lanosterol 14 alpha methyl demethylase inhibitors and suppressors of hmgr activity FASEB Journal 2(4): Abstract 1651
Zhao, Q.-J.; Hu, H.-G.; Li, Y.-W.; Song, Y.; Cai, L.-Z.; Wu, Q.-Y.; Jiang, Y.-Y. 2007: Design, synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14 alpha-demethylase (CYP51) Chemistry and Biodiversity 4(7): 1472-1479
Ji, H.; Zhang, W.; Zhang, M.; Kudo, M.; Aoyama, Y.; Yoshida, Y.; Sheng, C.; Song, Y.; Yang, S.; Zhou, Y.; Lü, J.; Zhu, Jü. 2003: Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi Journal of Medicinal Chemistry 46(4): 474-485
Magolda, R.L.; Chen, H.; Favata, M.F.; Fischer, R.T.; Gaylor, J.L.; Johnson, P.R.; Ko, S.S.; Stam, S.H.; Trzaskos, J.M. 1987: Design and synthesis of lanosterol 14 alpha methyl demethylase inhibitors and suppressors of hmgr activity part iii. mechanism based inhibitor Abstracts of Papers American Chemical Society 194: MEDI 78
Frye, L.; Leonard, D. 1992: Dual action inhibitors of cholesterol biosynthesis: lanosterol analogs that inhibit lanosterol 14 alpha-methyl demethylase and suppress 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity ACS Symposium series American Chemical Society: 97) 94-108
Tuck, S.F.; Patel, H.; Safi, E.; Robinson, C.H. 1991: Lanosterol 14 alpha-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol Journal of Lipid Research 32(6): 893-902
Huff, S.; Kummetha, I.R.; Zhang, L.; Wang, L.; Bray, W.; Yin, J.; Kelley, V.; Wang, Y.; Rana, T.M. 2022: Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents Journal of Medicinal Chemistry 65(16): 10920-10937
Selberg, S.; Seli, N.; Kankuri, E.; Karelson, M. 2021: Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors Acs Omega 6(20): 13310-13320
Yang, R.; Mccollum, G.W.; Zhu, L.; Head, W.S.; O'day, D.M.; Wang, M.X. 1999: RT-PCR of fungal specific lanosterol-14alpha-demethylase mRNA in a rabbit model of C albicans keratitis IOVS Investigative Ophthalmology and Visual Science 40(4): S551
Wang, T.; Liu, Y.; Zhang, H.; Fang, Z.; Zhang, R.; Zhang, W.; Fan, Y.; Xiang, R. 2021: Crystal structures of two inhibitors in complex with histone lysine demethylase 4D (KDM4D) provide new insights for rational drug design Biochemical and Biophysical Research Communications 554: 71-75
Tuck, S.F.; Robinson, C.H. 1990: Inhibitors of rat liver lanosterol 14 alpha demethylase oxiranyl and thiiranyllanosterols Abstracts of Papers American Chemical Society 199(1-2): ORGN 41
Sagatova, A.A.; Keniya, M.V.; Wilson, R.K.; Sabherwal, M.; Tyndall, J.D.A.; Monk, B.C. 2016: Triazole resistance mediated by mutations of a conserved active site tyrosine in fungal lanosterol 14α-demethylase Scientific Reports 6: 26213
Friggeri, L.; Hargrove, T.Y.; Rachakonda, G.; Williams, A.D.; Wawrzak, Z.; Di Santo, R.; De Vita, D.; Waterman, M.R.; Tortorella, S.; Villalta, F.; Lepesheva, G.I. 2014: Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14α-demethylase: two regions of the enzyme molecule potentiate its inhibition Journal of Medicinal Chemistry 57(15): 6704-6717
Frye, L.L.; Robinson, C.H. 1988: Novel inhibitors of lanosterol 14 alpha methyl demethylase a critical enzyme in cholesterol biosynthesis Journal of the Chemical Society Chemical Communications 2: 129-131
Korosec, T.; Acimovic, J.; Seliskar, M.; Kocjan, D.; Tacer, K.F.; Rozman, D.; Urleb, U. 2008: Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51) Bioorganic and Medicinal Chemistry 16(1): 209-221